CRTAC1 and non-small cell lung carcinoma: Treatment with dantrolene decreased intracellular Ca2+ levels in CRTAC1-overexpressing NSCLC cells, whereas 2-APB had no effect (Fig. 7O–R and Supplementary Fig. S1).